G9653 — Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months
G9653 is a HCPCS Level II code for patient has not been treated with a systemic or biologic medication for psoriasis for at least six months. It belongs to the Procedures and Professional Services (Temporary) section. It was terminated on December 31, 2016 and is not valid on new claims.
This code has been terminated
CMS terminated G9653 on December 31, 2016. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for G9653
- Long descriptor
- Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months
- Short descriptor
- Pt no tx sys bio rx 6 mths
- Added
- January 1, 2016
- Terminated
- December 31, 2016
- BETOS
- Z2
- Pricing indicator
- 00 — Not priced by Part B
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.
Codes adjacent to G9653
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If G9653 is not quite right, the correct code is very often within a few positions of it.
- G9645Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure
- G9646Patients with 90 day mrs score of 0 to 2
- G9647Patients in whom mrs score could not be obtained at 90 day follow-upterminated
- G9648Patients with 90 day mrs score greater than 2
- G9649Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))
- G9650Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqiterminated
- G9651Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented
- G9652Patient has been treated with a systemic or biologic medication for psoriasis for at least six monthsterminated
- G9654Monitored anesthesia care (mac)
- G9655A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used
- G9656Patient transferred directly from anesthetizing location to pacu or other non-icu location
- G9657Transfer of care during an anesthetic or to the intensive care unitterminated
- G9658A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used
- G9659Patients greater than or equal to 86 years of age who underwent a screening colonoscopy and did not have a history of colorectal cancer or other valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits
- G9660Documentation of medical reason(s) for a colonoscopy performed on a patient greater than or equal to 86 years of age (e.g., iron deficiency anemia, lower gastrointestinal bleeding, familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits)
- G9661Patients greater than or equal to 86 years of age who received a colonoscopy for an assessment of signs/symptoms of gi tract illness, and/or because the patient meets high risk criteria, and/or to follow-up on previously diagnosed advanced lesions
Questions about G9653
What is HCPCS code G9653?
G9653 is a HCPCS Level II code for patient has not been treated with a systemic or biologic medication for psoriasis for at least six months. It sits in the Procedures and Professional Services (Temporary) section.
Does Medicare cover G9653?
The CMS HCPCS file marks G9653 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is G9653 still valid?
No. G9653 was terminated on December 31, 2016 and should not be used on new claims.